Imatinib for the treatment of patients with unresectable and/or metastatic gastro-intestinal stromal tumours - a systematic review and economic evaluation

S Fujian; Martin Connock; Anne Fry-Smith; J Raftery; J Wilson; L Yao

Imatinib for the treatment of patients with unresectable and/or metastatic gastro-intestinal stromal tumours - a systematic review and economic evaluation

S Fujian
, Martin Connock
, Anne Fry-Smith
, J Raftery
, J Wilson
, L Yao

Research output: Book/Report › Book

Original language	English
Publisher	National Institute for Clinical Excellence
Publication status	Published - 1 Jan 2003

Cite this

@book{78df3b8b774d44d5848c563e3303f89f,

title = "Imatinib for the treatment of patients with unresectable and/or metastatic gastro-intestinal stromal tumours - a systematic review and economic evaluation",

author = "S Fujian and Martin Connock and Anne Fry-Smith and J Raftery and J Wilson and L Yao",

year = "2003",

month = jan,

day = "1",

language = "English",

publisher = "National Institute for Clinical Excellence",

}

TY - BOOK

T1 - Imatinib for the treatment of patients with unresectable and/or metastatic gastro-intestinal stromal tumours - a systematic review and economic evaluation

AU - Fujian, S

AU - Connock, Martin

AU - Fry-Smith, Anne

AU - Raftery, J

AU - Wilson, J

AU - Yao, L

PY - 2003/1/1

Y1 - 2003/1/1

M3 - Book

BT - Imatinib for the treatment of patients with unresectable and/or metastatic gastro-intestinal stromal tumours - a systematic review and economic evaluation

PB - National Institute for Clinical Excellence

ER -